Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update
- PMID: 22715214
- DOI: 10.1093/cid/cis363
Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update
Abstract
Hepatitis C virus (HCV) infection is a complex public health problem, characterized by a high prevalence of chronic infection, an increasing burden of HCV-associated disease, low rates of testing and treatment, and the prospect of increasing incidence associated with the epidemic of injection drug use. Three-quarters of chronic HCV infections occur among persons born from 1945 through 1965. Prevention efforts are complicated by limited knowledge among health care professionals, persons at risk and in the public at large. At the Centers for Disease Control and Prevention, efforts to improve primary and secondary prevention effectiveness center on policy development, education and training initiatives, and applied research. This report provides a brief overview of some of these efforts, including the development of testing recommendations for the 1945-1965 birth cohort, research and evaluation studies in settings where persons who inject drugs receive services, and a national viral hepatitis education campaign that targets health care professionals, the public, and persons at risk.
Similar articles
-
Hepatitis C virus prevention, care, and treatment: from policy to practice.Clin Infect Dis. 2012 Jul;55 Suppl 1:S58-63. doi: 10.1093/cid/cis392. Clin Infect Dis. 2012. PMID: 22715216
-
Global burden of hepatitis C: considerations for healthcare providers in the United States.Clin Infect Dis. 2012 Jul;55 Suppl 1:S10-5. doi: 10.1093/cid/cis361. Clin Infect Dis. 2012. PMID: 22715208
-
Surveillance for acute viral hepatitis - United States, 2007.MMWR Surveill Summ. 2009 May 22;58(3):1-27. MMWR Surveill Summ. 2009. PMID: 19478727
-
Planning a hepatitis C postexposure management program for health care workers. Issues and challenges.AAOHN J. 2000 Aug;48(8):370-5. AAOHN J. 2000. PMID: 11760299 Review.
-
Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.Int J Drug Policy. 2007 Oct;18(5):417-25. doi: 10.1016/j.drugpo.2007.01.013. Epub 2007 Feb 20. Int J Drug Policy. 2007. PMID: 17854731 Review.
Cited by
-
Hepatitis C Virus in the Elderly in the Direct-Acting Antiviral Era: from Diagnosis to Cure.Curr Treat Options Infect Dis. 2020;12(3):296-309. doi: 10.1007/s40506-020-00231-8. Epub 2020 Aug 11. Curr Treat Options Infect Dis. 2020. PMID: 32837340 Free PMC article. Review.
-
Molecular pathways: hepatitis C virus, CXCL10, and the inflammatory road to liver cancer.Clin Cancer Res. 2013 Mar 15;19(6):1347-52. doi: 10.1158/1078-0432.CCR-12-0928. Epub 2013 Jan 15. Clin Cancer Res. 2013. PMID: 23322900 Free PMC article. Review.
-
Intention to Screen for Hepatitis C Among University Students: Influence of Different Communicative Scenarios.Front Psychiatry. 2022 May 11;13:873566. doi: 10.3389/fpsyt.2022.873566. eCollection 2022. Front Psychiatry. 2022. PMID: 35633800 Free PMC article.
-
Substance use and hepatitis C: an ecological momentary assessment study.Health Psychol. 2014 Jul;33(7):710-9. doi: 10.1037/hea0000087. Health Psychol. 2014. PMID: 24977312 Free PMC article.
-
Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma.Liver Transpl. 2012 Dec;18(12):1471-8. doi: 10.1002/lt.23551. Liver Transpl. 2012. PMID: 23008049 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical